HEPATITIS C
Merilisa HCV is an Enzyme Immunoassay for the qualitative determination of antibodies to Hepatitis C Virus iin human serum and plasma.
- Capture antigens - Core, NS3, NS4 and NS4
- Recombinant proteins used for better sensitivity
- Sample Addition montitoring
- Increased standardization, test robustness and reproducibility
Benefits
01
Detects all major genotypes of HCV
02
Convenient microwell sample dilutions
03
Adaptable on all automated ELISA processors
04
Diagnostic Sensitivity : 100%
05
Diagnostic Specificity : > 99.5%
Indication:
- Detection of antibodies to Hepatitis C virus in human serum or plasma
Product Specifications
| Intended Use | Enzyme Immunoassay for qualitative determination of antibodies against HCV virus in human serum and plasma |
| Principle | Sandwich Immunoassay |
| Technique | ELISA |
| Detection | Antibodies to HCV |
| Capture | Recombinant antigens (Core, NS3,NS4,NS5) |
| Conjugate | Anti human IgG conjugated with Horse Radish Peroxidase |
| Type of Specimen required | Serum or Plasma |
| Total incubation time | 90 minutes |
| Diagnostic Sensitivity | 100% |
| Diagnostic Specificity | > 99.5% |
| Evaluation | National Institute of Biologicals |
Ordering Information
| Product Code | Material Description | Pack Size |
|---|---|---|
| HPCELI-01 | Merilisa HCV | 96 Wells |
Clinical Data
Product IFU
Note: IFU will be displayed after MDR Certification